<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-title>Trials</journal-title><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2651873</article-id><article-id pub-id-type="publisher-id">1745-6215-10-7</article-id><article-id pub-id-type="doi">10.1186/1745-6215-10-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting &#x02013; rationale, design and baseline characteristics</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Laurence</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>caroline.laurence@adelaide.edu.au  </email></contrib><contrib id="A2" contrib-type="author"><name><surname>Gialamas</surname><given-names>Angela</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>angela.gialamas@adelaide.edu.au  </email></contrib><contrib id="A3" contrib-type="author"><name><surname>Yelland</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>lisa.yelland@adelaide.edu.au  </email></contrib><contrib id="A4" contrib-type="author"><name><surname>Bubner</surname><given-names>Tanya</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tanya.bubner@adelaide.edu.au  </email></contrib><contrib id="A5" contrib-type="author"><name><surname>Ryan</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>philip.ryan@adelaide.edu.au  </email></contrib><contrib id="A6" contrib-type="author"><name><surname>Willson</surname><given-names>Kristyn</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>kristyn.willson@adelaide.edu.au  </email></contrib><contrib id="A7" contrib-type="author"><name><surname>Glastonbury</surname><given-names>Briony</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>bglastonbury@eye.usyd.edu.au  </email></contrib><contrib id="A8" contrib-type="author"><name><surname>Gill</surname><given-names>Janice</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>jan.gill@rcpaqap.com.au  </email></contrib><contrib id="A9" contrib-type="author"><name><surname>Shephard</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>mark.shephard@flinders.edu.au  </email></contrib><contrib id="A10" contrib-type="author"><name><surname>Beilby</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Justin.beilby@adelaide.edu.au  </email></contrib><contrib id="A11" contrib-type="author"><collab>for members of the PoCT Trial Management Committee</collab><email>caroline.laurence@adelaide.edu.au  </email></contrib></contrib-group><aff id="I1"><label>1</label>Discipline of General Practice, The University of Adelaide, Adelaide, South Australia, Australia</aff><aff id="I2"><label>2</label>Discipline of Public Health, The University of Adelaide, Adelaide, South Australia, Australia</aff><aff id="I3"><label>3</label>Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia</aff><aff id="I4"><label>4</label>RCPA Quality Assurance Programs Pty Ltd, Adelaide, South Australia, Australia</aff><aff id="I5"><label>5</label>Community Point-of-Care Services, Flinders University Rural Clinical School, Flinders University, Adelaide, South Australia, Australia</aff><aff id="I6"><label>6</label>Faculty of Health Sciences, The University of Adelaide, Adelaide, South Australia, Australia</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>28</day><month>1</month><year>2009</year></pub-date><volume>10</volume><fpage>7</fpage><lpage>7</lpage><ext-link ext-link-type="uri" xlink:href="http://www.trialsjournal.com/content/10/1/7"/><history><date date-type="received"><day>16</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Laurence et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Laurence et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Laurence
               Caroline
               
               caroline.laurence@adelaide.edu.au  
            </dc:author><dc:title>
            A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting &#x02013; rationale, design and baseline characteristics
         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Trials 10(1): 7-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1745-6215(2009)10:1&#x0003c;7&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1745-6215</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><related-article related-article-type="corrected-article" vol="9" page="50" id="N0x1e80cd0N0x306bea0" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="18681979" ext-link-type="pubmed"/></article-meta></front><body><p>Following the publication of our article [<xref ref-type="bibr" rid="B1">1</xref>] we noticed an error within Additional file 2: Comparison of patient baseline characteristics by condition. The column headings 'Control' and 'Intervention' are incorrectly positioned in the table and should be switched.</p><p>The table should therefore appear as shown in Table <xref ref-type="table" rid="T1">1</xref> in this correction.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Comparison of patient baseline characteristics by condition</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Condition Group</td><td align="left">Characteristic</td><td></td><td align="left">Control n (%)</td><td align="left">Intervention n (%)</td><td align="left">Total n (%)</td></tr></thead><tbody><tr><td align="left">Diabetes</td><td></td><td></td><td align="left">N = 785</td><td align="left">N = 1182</td><td align="left">N = 1967</td></tr><tr><td></td><td align="left">Male</td><td></td><td align="left">432 (55.0)</td><td align="left">651 (55.1)</td><td align="left">1083 (55.1)</td></tr><tr><td></td><td align="left">Age (years)</td><td align="left">Median (IQ range)</td><td align="left">67.0 (59.0&#x02013;74.0)</td><td align="left">66.0 (58.0&#x02013;73.0)</td><td align="left">66.0 (59.0&#x02013;73.0)</td></tr><tr><td></td><td align="left">Aboriginal and Torres Strait Islander</td><td align="left">Yes</td><td align="left">4 (0.5)</td><td align="left">23 (1.9)</td><td align="left">27 (1.4)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">723 (92.1)</td><td align="left">1036 (87.6)</td><td align="left">1759 (89.4)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">58 (7.4)</td><td align="left">123 (10.4)</td><td align="left">181 (9.2)</td></tr><tr><td></td><td align="left">BMI</td><td align="left">Underweight</td><td align="left">5 (0.6)</td><td align="left">3 (0.3)</td><td align="left">8 (0.4)</td></tr><tr><td></td><td></td><td align="left">Normal</td><td align="left">121 (15.4)</td><td align="left">181 (15.3)</td><td align="left">302 (15.4)</td></tr><tr><td></td><td></td><td align="left">Overweight</td><td align="left">243 (31.0)</td><td align="left">386 (32.7)</td><td align="left">629 (32.0)</td></tr><tr><td></td><td></td><td align="left">Obese</td><td align="left">334 (42.5)</td><td align="left">464 (39.3)</td><td align="left">798 (40.6)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">82 (10.4)</td><td align="left">148 (12.5)</td><td align="left">230 (11.7)</td></tr><tr><td></td><td align="left">HbA1c %</td><td align="left">Median (IQ range)</td><td align="left">7.1 (6.3&#x02013;8.0)</td><td align="left">6.9 (6.2&#x02013;7.7)</td><td align="left">7.0 (6.3&#x02013;7.8)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">64 (8.2)</td><td align="left">90 (7.6)</td><td align="left">154 (7.8)</td></tr><tr><td></td><td align="left">Diabetes management:</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="left">Dietary control</td><td align="left">Yes</td><td align="left">446 (56.8)</td><td align="left">604 (51.1)</td><td align="left">1050 (53.4)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">309 (39.4)</td><td align="left">503 (42.6)</td><td align="left">812 (41.3)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">30 (3.8)</td><td align="left">75 (6.3)</td><td align="left">105 (5.3)</td></tr><tr><td></td><td align="left">Insulin</td><td align="left">Yes</td><td align="left">145 (18.5)</td><td align="left">204 (17.3)</td><td align="left">349 (17.7)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">610 (77.7)</td><td align="left">903 (76.4)</td><td align="left">1513 (76.9)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">30 (3.8)</td><td align="left">75 (6.3)</td><td align="left">105 (5.3)</td></tr><tr><td></td><td align="left">Prescription tablets</td><td align="left">Yes</td><td align="left">541 (68.9)</td><td align="left">729 (61.7)</td><td align="left">1270 (64.6)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">214 (27.3)</td><td align="left">378 (32.0)</td><td align="left">592 (30.1)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">30 (3.8)</td><td align="left">75 (6.3)</td><td align="left">105 (5.3)</td></tr><tr><td></td><td align="left">Years since first diagnosed</td><td align="left">&#x0003c; 1 year</td><td align="left">39 (5.0)</td><td align="left">67 (5.7)</td><td align="left">106 (5.4)</td></tr><tr><td></td><td></td><td align="left">1&#x02013;5 years</td><td align="left">256 (32.6)</td><td align="left">403 (34.1)</td><td align="left">659 (33.5)</td></tr><tr><td></td><td></td><td align="left">6&#x02013;10 years</td><td align="left">201 (25.6)</td><td align="left">235 (19.9)</td><td align="left">436 (22.2)</td></tr><tr><td></td><td></td><td align="left">&#x0003e; 10 years</td><td align="left">230 (29.3)</td><td align="left">311 (26.3)</td><td align="left">541 (27.5)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">59 (7.5)</td><td align="left">166 (14.0)</td><td align="left">225 (11.4)</td></tr><tr><td align="left">Hyperlipidaemia</td><td></td><td></td><td align="left">N = 1463</td><td align="left">N = 2356</td><td align="left">N = 3819</td></tr><tr><td></td><td align="left">Male</td><td></td><td align="left">753 (51.5)</td><td align="left">1277 (54.2)</td><td align="left">2030 (53.2)</td></tr><tr><td></td><td align="left">Age (years)</td><td align="left">Median (IQ range)</td><td align="left">68.0 (60.0&#x02013;74.0)</td><td align="left">66.0 (58.0&#x02013;74.0)</td><td align="left">66.0 (59.0&#x02013;74.0)</td></tr><tr><td></td><td align="left">Aboriginal and Torres Strait Islander</td><td align="left">Yes</td><td align="left">9 (0.6)</td><td align="left">26 (1.1)</td><td align="left">35 (0.9)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">1342 (91.7)</td><td align="left">2102 (89.2)</td><td align="left">3444 (90.2)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">112 (7.7)</td><td align="left">228 (9.7)</td><td align="left">340 (8.9)</td></tr><tr><td></td><td align="left">Index of Relative Socio-Economic Disadvantage</td><td align="left">1<sup>st </sup>quartile</td><td align="left">251 (17.2)</td><td align="left">575 (24.4)</td><td align="left">826 (21.6)</td></tr><tr><td></td><td></td><td align="left">2<sup>nd </sup>quartile</td><td align="left">476 (32.5)</td><td align="left">756 (32.1)</td><td align="left">1232 (32.3)</td></tr><tr><td></td><td></td><td align="left">3<sup>rd </sup>quartile</td><td align="left">390 (26.7)</td><td align="left">663 (28.1)</td><td align="left">1053 (27.6)</td></tr><tr><td></td><td></td><td align="left">4<sup>th </sup>quartile</td><td align="left">346 (23.7)</td><td align="left">362 (15.4)</td><td align="left">708 (18.5)</td></tr><tr><td></td><td align="left">Co-morbid conditions:</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="left">Known heart disease</td><td align="left">Yes</td><td align="left">540 (36.9)</td><td align="left">812 (34.5)</td><td align="left">1352 (35.4)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">869 (59.4)</td><td align="left">1398 (59.3)</td><td align="left">2267 (59.4)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">54 (3.7)</td><td align="left">146 (6.2)</td><td align="left">200 (5.2)</td></tr><tr><td></td><td align="left">Diabetes</td><td></td><td align="left">509 (34.8)</td><td align="left">853 (36.2)</td><td align="left">1362 (35.7)</td></tr><tr><td></td><td align="left">Smoking status</td><td align="left">Current</td><td align="left">103 (7.0)</td><td align="left">201 (8.5)</td><td align="left">304 (8.0)</td></tr><tr><td></td><td></td><td align="left">Ex-smoker</td><td align="left">644 (44.0)</td><td align="left">1001 (42.5)</td><td align="left">1645 (43.1)</td></tr><tr><td></td><td></td><td align="left">Never smoked</td><td align="left">654 (44.7)</td><td align="left">990 (42.0)</td><td align="left">1644 (43.0)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">62 (4.2)</td><td align="left">164 (7.0)</td><td align="left">226 (5.9)</td></tr><tr><td></td><td align="left">Total cholesterol</td><td align="left">Median (IQ range)</td><td align="left">4.7 (4.0&#x02013;5.4)</td><td align="left">4.6 (4.0&#x02013;5.4)</td><td align="left">4.7 (4.0&#x02013;5.4)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">99 (6.8)</td><td align="left">186 (7.9)</td><td align="left">285 (7.5)</td></tr><tr><td></td><td align="left">Triglyceride</td><td align="left">Median (IQ range)</td><td align="left">1.6 (1.1&#x02013;2.2)</td><td align="left">1.6 (1.2&#x02013;2.2)</td><td align="left">1.6 (1.2&#x02013;2.2)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">185 (12.6)</td><td align="left">204 (8.7)</td><td align="left">389 (10.2)</td></tr><tr><td></td><td align="left">HDL-C</td><td align="left">Median (IQ range)</td><td align="left">1.3 (1.1&#x02013;1.6)</td><td align="left">1.3 (1.1&#x02013;1.5)</td><td align="left">1.3 (1.1&#x02013;1.6)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">239 (16.3)</td><td align="left">515 (21.9)</td><td align="left">754 (19.7)</td></tr><tr><td align="left">Anticoagulant therapy</td><td></td><td></td><td align="left">N = 372</td><td align="left">N = 572</td><td align="left">N = 944</td></tr><tr><td></td><td align="left">Male</td><td></td><td align="left">217 (58.3)</td><td align="left">326 (57.0)</td><td align="left">543 (57.5)</td></tr><tr><td></td><td align="left">Age (years)</td><td align="left">Median (IQ range)</td><td align="left">73.0 (66.0&#x02013;79.0)</td><td align="left">73.0 (65.0&#x02013;78.0)</td><td align="left">73.0 (65.0&#x02013;79.0)</td></tr><tr><td></td><td align="left">BMI</td><td align="left">Underweight</td><td align="left">7 (1.9)</td><td align="left">5 (0.9)</td><td align="left">12 (1.3)</td></tr><tr><td></td><td></td><td align="left">Normal</td><td align="left">90 (24.2)</td><td align="left">165 (28.8)</td><td align="left">255 (27.0)</td></tr><tr><td></td><td></td><td align="left">Overweight</td><td align="left">130 (34.9)</td><td align="left">190 (33.2)</td><td align="left">320 (33.9)</td></tr><tr><td></td><td></td><td align="left">Obese</td><td align="left">111 (29.8)</td><td align="left">132 (23.1)</td><td align="left">243 (25.7)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">34 (9.1)</td><td align="left">80 (14.0)</td><td align="left">114 (12.1)</td></tr><tr><td></td><td align="left">Multiple co-morbidities</td><td align="left">Yes</td><td align="left">170 (45.7)</td><td align="left">285 (49.8)</td><td align="left">455 (48.2)</td></tr><tr><td></td><td></td><td align="left">No</td><td align="left">186 (50.0)</td><td align="left">259 (45.3)</td><td align="left">445 (47.1)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">16 (4.3)</td><td align="left">28 (4.9)</td><td align="left">44 (4.7)</td></tr><tr><td></td><td align="left">INR</td><td align="left">Below target range</td><td align="left">73 (19.6)</td><td align="left">115 (20.1)</td><td align="left">188 (19.9)</td></tr><tr><td></td><td></td><td align="left">Within target range</td><td align="left">197 (53.0)</td><td align="left">316 (55.2)</td><td align="left">513 (54.3)</td></tr><tr><td></td><td></td><td align="left">Above target range</td><td align="left">37 (9.9)</td><td align="left">63 (11.0)</td><td align="left">100 (10.6)</td></tr><tr><td></td><td></td><td align="left">Missing</td><td align="left">65 (17.5)</td><td align="left">78 (13.6)</td><td align="left">143 (15.1)</td></tr></tbody></table></table-wrap></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laurence</surname><given-names>C</given-names></name><name><surname>Gialamas</surname><given-names>A</given-names></name><name><surname>Yelland</surname><given-names>L</given-names></name><name><surname>Bubner</surname><given-names>T</given-names></name><name><surname>Ryan</surname><given-names>P</given-names></name><name><surname>Willson</surname><given-names>K</given-names></name><name><surname>Glastonbury</surname><given-names>B</given-names></name><name><surname>Gill</surname><given-names>J</given-names></name><name><surname>Shepard</surname><given-names>M</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><collab>for members of the PoCT Trial Management Committee</collab></person-group><article-title>A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting &#x02013; rationale, design and baseline characteristics</article-title><source>Trials</source><year>2008</year><volume>9</volume><fpage>50</fpage><pub-id pub-id-type="pmid">18681979</pub-id><pub-id pub-id-type="doi">10.1186/1745-6215-9-50</pub-id></citation></ref></ref-list></back></article>


